Analyst Ratings February 24, 2026

Deutsche Bank Lowers Rentokil Initial Rating Citing Margin Shortfall; BofA Sees Upside from Terminix Integration

Analysts diverge as Deutsche Bank trims target and flags under-earning in pest control; BofA raises its view on integration progress

By Avery Klein RTO
Deutsche Bank Lowers Rentokil Initial Rating Citing Margin Shortfall; BofA Sees Upside from Terminix Integration
RTO

Deutsche Bank downgraded Rentokil Initial Plc. to Hold from Buy and cut its price target to GBP4.65 from GBP5.05, citing a margin gap in the Pest Control category versus international peers and uncertainty around how the incoming CEO will close that gap. The broker flagged potential near-term pressure from investments to lift organic growth. Separately, BofA Securities upgraded Rentokil to Buy and raised its target to GBP5.10 from GBP4.25, pointing to progress integrating Terminix and the prospect of a rerating by 2026.

Key Points

  • Deutsche Bank downgraded Rentokil Initial from Buy to Hold and lowered its price target to GBP4.65 from GBP5.05.
  • InvestingPro data shows a gross profit margin of 83% over the last twelve months, but the stock trades at a P/E of 59.3; InvestingPro�s Fair Value analysis still suggests slight undervaluation.
  • BofA upgraded Rentokil from Neutral to Buy and raised its target to GBP5.10 from GBP4.25, citing Terminix integration progress and potential rerating by 2026.

Overview

Deutsche Bank updated its recommendation on Rentokil Initial Plc. (NYSE:RTO), moving the stock from Buy to Hold and trimming the firm�s price target to GBP4.65 from GBP5.05. The broker characterized Rentokil as a global market leader operating in an attractive, defensive sector, but expressed concern that the company�s Pest Control division is not generating margins on par with leading international peers.

Profitability and valuation metrics

Deutsche Bank noted that, while Rentokil has maintained a strong gross profit profile, some operating segments are under-earning. InvestingPro data cited by analysts shows the company posted a gross profit margin of 83% over the last twelve months. At the same time, the shares trade at a high price-to-earnings multiple of 59.3. InvestingPro�s Fair Value analysis, however, still suggests the stock is slightly undervalued at current levels.

Margin shortfall in Pest Control

The broker�s work points specifically to the Pest Control category as the area falling short relative to comparable international operators. Deutsche Bank said it is awaiting more detail from Rentokil�s incoming chief executive on the pathway to close the growth and margin gaps to peers over time. The bank highlighted that management decisions, including potential increases in investment to stimulate organic revenue growth, could exert pressure on near-term forecasts. It also acknowledged that such investment might be appropriate to drive longer-term improvement.

Market listings

In addition to its NYSE listing under RTO, Rentokil Initial also trades on the London Stock Exchange under the ticker RTO:LN.

Contrasting view from BofA

In separate analyst activity, BofA Securities upgraded Rentokil from Neutral to Buy and lifted its price target to GBP5.10 from GBP4.25. BofA attributes its more positive stance to progress in integrating Terminix, which the firm sees as a material factor that could contribute to a potential rerating by 2026. The bank added Rentokil to its "25 stocks for 2026" list as well as its Europe 1 list of top ideas, signaling increased optimism about the company�s strategic moves.

Investor resources and monitoring

InvestingPro is noted as offering five additional tips for RTO investors and provides financial health metrics to help track the company�s turnaround progress. These resources are intended to assist investors monitoring whether planned investments and integration milestones translate into improved growth and margin outcomes.


Conclusion

Analyst opinions on Rentokil diverge: Deutsche Bank has moved to a more cautious stance focused on closing a margin gap in Pest Control and the potential short-term impact of investment, while BofA points to operational progress from the Terminix integration and anticipates upside over a multi-year horizon. Market participants looking at Rentokil will likely weigh near-term investment-driven pressure against longer-term structural benefits from integration and recovery in under-earning segments.

Risks

  • Increased investment to improve organic revenue growth could pressure near-term forecasts - impacts company earnings and could affect investor sentiment in the industrials and services sectors.
  • The Pest Control category is materially under-earning versus international peers, creating uncertainty around margin recovery timelines - affects sector profitability expectations.
  • Dependence on execution by incoming CEO to close growth and margin gaps creates leadership and execution risk - could influence market and corporate service providers.

More from Analyst Ratings

BofA Lifts Arm Holdings Price Target as Firm Sees Bigger CPU Market Share Opportunity Feb 24, 2026 Mizuho Lowers Boston Properties Rating, Cites West Coast and Tech Exposure as Headwinds Feb 24, 2026 Mizuho Lowers Kilroy Realty Rating, Flags Leasing and Tech-Tenant Credit Risks Feb 24, 2026 Barclays Lowers Gossamer Bio Rating After Phase 3 Setback; Balance Sheet Concerns Highlighted Feb 24, 2026 Citizens Sticks With Market Outperform for Summit Therapeutics as Ivonesimab Program Expands Feb 24, 2026